Oats products as Functional Food;Produkty owsiane jako żywność funkcjonalna

Zywnosc. Nauka. Technologia. Jakosc/Food. Science Technology. Quality

Volumn 17, Issue 3, 2010, Pages 7-24

  Lange, Ewa ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Diet related diseases; Functional food; Oat products

Indexed keywords

AVENA;

EID: 77956905353     PISSN: 14256959     EISSN: None     Source Type: Journal    
DOI: 10.15193/zntj/2010/70/007-024     Document Type: Article

References (69)

1. Amundsen A., Haugum B., Andersson H.: Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate within a controlled diet. Scand. J. Nutr., 2003, 47, 68-74.
2. Andon M., Anderson J.: State of the Art Reviews: The oatmeal-cholesterol connection: 10 years later. Am. J. Lifestyle Med., 2008, 2, 51-57.
3. Angelov A., Gotcheva V., Kuncheva R., Hristozova T.: Development of a new oat-based probiotic drink Intern. J. Food Microbiol., 2006, 112, 75-80.
4. Bartnikowska E., Lange E.: Influence of naked oat and its extruded products on lipid metabolism in rats fed atherogenic diet. Pol. J. Food Nutr. Sci., 2000, 9, 63-71.
5. Behall K., Scholfield D., Hallfrisch J.: Comparison of hormone and glucose responses of overweight women to barley and oats. Am. J. Coll. Nutr., 2005, 24, 182-188.
6. Berg A., König D., Deibert P., Grathwohl D., Berg A., Baumstark M., Ingomar-Werner F.: Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann. Nutr. Metab., 2003, 47, 306-311.
7. Biörklund M., van Rees A., Mensink R., Önning G.: Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with β-glucans from oats or barley: a randomised dose-controlled trial. Eur. J. Clin. Nutr., 2005, 59, 1272-1281.
8. Brown L., Bernard R., Willett W., Sacks F.: Cholesterol-lowering effects of dietary fiber: a metaanalysis. Am. J. Clin. Nutr., 1999, 69, 30-42.
9. Butt M., Tahir-Nadeem M., Kashif Iqbal Khan M., Shabir R., Butt M. S.: Oat: unique among the cereals. Eur. J. Nutr., 2008, 47, 68-79.
10. Chen C.-Y., Milbury P., Collins F., Blumberg J.: Avenanthramides are bio-available and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J. Nutr., 2007, 137, 1375-1382.
11. Chen Ch-Y., Milbury P., Kwak H-K., Collins F., Samuel P., Blumberg J.: Avenanthramides and phenolic acids from oats are bio-available and act synergistically with vitamin c to enhance hamster and human LDL resistance to oxidation. J. Nutr., 2004, 134, 1459-1466.
12. Chen J., Huangi X.: The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. J. Clin. Lipidol., 2009, 3, 154-158.
13. Chizzolini R., Zanardi E., Dorigoni V., Ghidinii S.,: Trends in Food Sci. Technol., 1999, 10, 119-128.
14. Codex standard for foods for special dietary use for persons Intolerant to gluten. CODEX STAN 118-1979, Rev. 2008.
15. Davy B., Davy K., Ho R., Beske S., Davrath L., Melby Ch.: High-fiber oat cereal compared with heat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middleaged and older men. Am. J. Clin. Nutr., 2002, 76, 351-358.
16. de Groot A., Luyken R., Pikaar N.: Cholesterol-lowering effect of rolled oats. Lancet, 1968, 2, 303-304.
17. Diplock A. Aggett P, Ashwell M, Bornet, F, Fern E, Roberfroid M:. Scientific concepts of functional foods in Europe - Consensus Document. Br. J. Nutr., 1999, 81, 1-27.
18. Dongowski G.: Interactions between dietary fibre-rich preparations and glycol-conjugated bile acids in vitro. Food Chemistry, 2007, 104, 390-397.
19. Ellegård L., Andersson H.: Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur. J. Clin. Nutr., 2007, 61, 938-945.
20. Eurodiet. Core Report. Nutrition and diet for lifestyles in Europe: science and policy implications. Public Health Nutrition 2006, 4, 265-273.
21. European Food Safety Authority. Final scientific and technical guidance for applicants for preparation and presentation of the application for authorization of a health claim. EFSA 2007: http://www.efsa.europa.eu/EFSA/ ScientificPanels/NDA/efsa-locale-178620753812-Guidance467.htm
22. FAO. Food and Agriculture Organization Report on Functional Foods. 2007.
23. Food and Drug Administration. Evidence-Based Review System for the Scientific Evaluation of Health Claims. FDA 2007: http://www.cfsan.fda.gov/~dms/ hclmgui5.html
24. Foster-Powell K., Brand-Miller J.: International tables of glycemic index and glycemic load. Am. J. Clin. Nutr., 2002, 76, 5-56.
25. Ga̧siorowski H. (pod red.): Owies. Chemia i technologia. PWRiL Poznań 1995.
26. Granfeldt Y., Eliasson A-Ch., Björck I.: An examination of the possibility of lowering the glycemic index of oat and barley flakes by minimal processing. J. Nutr., 2000, 130, 2207-2214.
27. Granfeldt Y., Nyberg L., Björck I.: Muesli with 4 g oat β-glucans lowers glucose and insulin responses after a bread meal in healthy subjects. Eur. J. Clin. Nutr., 2008, 62, 600-607.
28. Gray D., Auerbach R., Hill S., Wang R., Campbell G., Webb C., South J.: Enrichment of oat antioxidant activity by dry milling and sieving. J. Cereal Sci., 2000, 32, 89-98.
29. Hawkes C.: Nutrition labels and health claims, the global regulatory environment. WHO, 2004.
30. Heller, I. R., Taniguchi, Y., Lobstein, T. Functional foods: Public health boon or 21st century quackery? Center for science in the public interest. http://www.cspinet.org/reports/functional-foods, 0112, 2009
31. Hepburn P., Howlett J., Boeing H., Cockburn A., Constable A., Davi A., de Jong N., Moseley B., Oberdörfer R., Robertson C., Wal J., Samuels F.: The Application of post-market monitoring to novel foods. Food Chem. Toxicol., 2008, 46, 9-33.
32. Hodan W., Buzby J.: Dietary assessment of major trends in U.S. food consumption, 1970-2005. Economic Research Service, U.S. Dept. of Agriculture. Economic Information Bulletin, 2008, 33.
33. Holt S., Brand Miller J., Farmakalidis E.: A satiety index of common foods. Eur. J. Clin. Nutr., 1995, 49, 675-690.
34. Hahn N.: Replacing fat with food technology. A brie review of new fat replacement ingredients. Am. J. Diet. Asocc., 1997, 7, 15-16.
35. Jenkins L., Jenkins D., Zdravkovic U., Wursch P., Vuksan V.: Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. 2002, Eur. .J. Clin. Nutr., 56, 622-628
36. Jones P.: Clinical nutrition: 7. Functional foods - more than just nutrition. CMAJ, 2002, 166, 1555-1563.
37. Kelly S., Summerbell C., Brynes A., Whittaker V., Frost G.: Wholegrain cereals for coronary heart disease (Review). Cochrane Database of Systematic Reviews, 2007, 2, CD005051. DOI: 10.1002/14651858.CD005051.pub2. (Pubitemid 351805947)
38. Lásztity R.: Oat grain - a wonderful reservoir of natural nutrients and biologically active substances. Food Rev. Int., 1998, 14, 99-119.
39. Li D., Wang M., Paul G., Pitot H., Dragan Y.: Dietary oat Lipids-induced novel DNA modifications and suppression of altered hepatic foci formation. Nutrition and Cancer, 1999, 33, 40-45.
40. Maki K., Galant R., Samuel P., Tesser J., Witchger M., Ribaya-Mercado J., Blumberg J., Geohas J.: Effects of consuming foods containing oat β-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur. J. Clin. Nutr., 2007, 61, 786-795.
41. McKevith B,: Nutritional aspects of cereals. Br. Nutr. Foundation Nutr. Bull., 2004, 29, 111-142.
42. Naumann E., van Rees A., Önning G., Öste R., Wydra M., Mensink R.: β-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am. J. Clin. Nutr., 2006, 83, 601-605.
43. Nie L., Wise M., Peterson D., Meydani M.: Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production. Atherosclerosis, 2006, 186, 260-266.
44. Nilsson U., Johansson M., Nilsson Å., Björck I., Nyman M.: Applied dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects. Eur. J. Clin. Nutr., 2008, 62, 978-984.
45. Nutrition Improvement Law Enforcement Regulations. Ministerial Ordinance No. 41, July 1991, Amendment to Ministerial Ordinance No. 33, May 25, 1996.
46. Önning G., Wallmark A., Persson M.: Consumption of Oat Milk for 5 Weeks Lowers Serum Cholesterol and LDL Cholesterol in Free-Living Men with Moderate Hypercholesterolemia. Ann. Nutr. Metab., 1999, 43, 301-309.
47. Peräaho M., Collin P., Kaukinen K., Kekkonen L., Miettinen S., Mäki M.: Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J. Am. Diet. Assoc., 2004,104, 1148-1150.
48. Peterson D.: Oat antioxidant. J. Cereal Science, 2001, 33, 115-129.
49. Pick M., Hawrysh Z., Gee M., Toth E, Garg M., Hardin R.: Oat Bran Concentrate Bread Products Improve Long-Term Control of Diabetes: A Pilot Study. J. Am. Diet. Assoc., 1996, 96, 1254-1261.
50. Pins J., Geleva D., Keenan J., Frazel C., O'Connor P., Cherney L.: Do wholegrain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? J. Fam. Pract., 2002, 51, 353-359.
51. Position of the American Dietetic Association: Functional Foods, J. Am. Diet. Assoc., 2009, 109, 735-746.
52. Queenan K., Stewart M., Smith K., Thomas W., Fulcher R., Slavin J.: Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J., 2007, 6, 6-14.
53. Regulation EC No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union, 2007, L 12318.
54. Reyna-Villasmil N., Bermúdez-Pirela V., Mengual-Moreno E., Arias N., Cano-Ponce C., Leal- Gonzalez E., Souki A., Inglett G., Israili Z., Hernández-Hernández R., Valasco M., Arraiz N.: Oatderived [beta]-glucan significantly improves hdlc and diminishes ldlc and non-hdl cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther, 2007, 14, 203-212.
55. Ripsin C., Keenan J., Jacobs D., Elmer P., Welch R., Van Horn L., Kiang L., Turnbull W., Thye F., Kestin M., Hegsted M., Davidson D ., Davidson M., Dugan L., Demark-Wahnefried W., Beling S.: Oat Products and Lipid Lowering. A Meta-analysis JAMA, 1992, 267, 3317-3325.
56. Robitaille J., Fontaine-Bisson B., Couture P., Tchernof A., Vohl M-C.: Effect of an oat bran-rich supplement on the metabolic profile of overweight premenopausal Women. Ann. Nutr. Metab., 2005, 49, 141-148.
57. Rozporza̧dzenie (WE) nr 1924/2006 Parlamentu Europejskiego i Rady z dnia 20 grudnia 2006r. w sprawie oświadczeń żywieniowych i zdrowotnych dotycza̧cych żywności. Dziennik Urzȩdowy Unii Europejskiej L 404 z 30 grudnia 2006r.
58. Saltzman E., Krupa Das S., Lichtenstein A., Dallal G., Corrales A., Schaefer E., Greenberg A., Roberts S.: An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J. Nutr., 2001, 131, 1465-1470.
59. Scientific Opinion on the substantiation of health claims related to β-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). European Food Safety Authority (EFSA). EFSA Journal 2009, 7 (1254), 1-18.
60. Souci S., Fachmann W., Kraut H.: Food composition and nutrition tables, MedPharm Scientific Publishers, Taylor and Francis, A RCR Press Book, Stuttgart 2008.
61. Tapola N., Karvonen H., Niskanen L., Mikola M., Sarkkineni E.: Glycemic responses of oat bran products in type 2 diabetic patients. Nutrition, Metabolism and Cardiovascular Diseases, 2005, 15, 255-261.
62. Taylor Ch., Wilkening V.: How the Nutrition Food Label Was Developed, Part 2: The Purpose and Promise of Nutrition Claims. J. Am. Diet. Assoc., 2008, 108, 618-623. (Pubitemid 351423381)
63. US Department of Health and Human Services, Food and Drug Administration. Health claims: oats and coronary heart disease -proposed rule. Fed Regist. 1996.
64. US Department of Health and Human Services, Food and Drug Administration. Health Claims. Guidance for Industry. A Food Labeling Guide. 21 CFR 101.81.
65. US Department of Health and Human Services, Food and Drug Administration. Health Claims. Guidance for Industry. A Food Labeling Guide. 21 CFR 101.76.
66. Wood J.: Oat bran. American Association of Cereal Chemists, St. Paul, MN 1993.
67. Wood, P.: Cereal β-glucans in diet and health. J Cereal. Sci., 2007, 46, 230-238.
68. Xu J., Chang, T., Inglett G., Carriere C., Tseng Y.: Multiple-particle tracking study of microheterogeneity of nutrim-10 Suspensions. Cereal Chem., 2006, 83, 37-41.
69. Zarkadas C., Yu Z., Burrow V.: Assessment of the protein quality of two new Canadian-developed oat cultivars by amino acid analysis. J. Agric. Food Chem. 1995, 43, 422-428.